INSPNYQHealthcare·Medical Devices#30 in industry

Inspire Medical Systems, Inc.

Reports in 7d· 2026-05-04

-32.7% · 90d

$55.07

-1.24 (-2.20%)

After-Hours $54.50(-0.57)

News

No News Yet

Press releases and SEC filings for INSP will appear here as they are published.

Check back later for updates

Key Data

Market Cap$1.59B

Open$55.85

Prev Close$56.31

Day Range$54.28 – $56.07

52W Range$48.30 – $163.35

Volume679,937

P/E (TTM)11.26

EPS$4.89

Dividend Yield—

Beta0.86

Profit Margin15.95%

Revenue Growth12.20%

Price Target$72.25(+31.2%)

Next Earnings2026-05-04(7d)

Analyst Ratings

Buy15 analysts

Buy 5Hold 10Sell 0

About

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Healthcare · Medical Devices

1,333 employees

www.inspiresleep.com